Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1 (2018)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.3332/ecancer.2018.831
- Subjects: NEOPLASIAS PULMONARES; CUIDADOS PALIATIVOS; PROGNÓSTICO; SOBREVIDA
- Language: Inglês
- Imprenta:
- Source:
- Título: Ecancermedicalscience
- ISSN: 1754-6605
- Volume/Número/Paginação/Ano: v. 12, article ID 831, 9p, 2018
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
CAIRES-LIMA, Rafael e HOFF, Paulo M. Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1. Ecancermedicalscience, v. 12, 2018Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2018.831. Acesso em: 12 mar. 2026. -
APA
Caires-lima, R., & Hoff, P. M. (2018). Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1. Ecancermedicalscience, 12. doi:10.3332/ecancer.2018.831 -
NLM
Caires-lima R, Hoff PM. Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1 [Internet]. Ecancermedicalscience. 2018 ; 12[citado 2026 mar. 12 ] Available from: https://doi.org/10.3332/ecancer.2018.831 -
Vancouver
Caires-lima R, Hoff PM. Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1 [Internet]. Ecancermedicalscience. 2018 ; 12[citado 2026 mar. 12 ] Available from: https://doi.org/10.3332/ecancer.2018.831 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
